COVID-19 and emerging viral infections: The case for interferon lambda is a research paper published in The Journal of Experimental Medicine (2020). On theSindex it has a DataRank of 0. It has been cited 208 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01AI39512
National Institutes of Health
Grant: R21AG064479-01
Wellcome Trust
Grant: 206200/Z/17/Z
Cancer Research UK
Grant: FC001206
National Institutes of Health
Grant: 1R01 AI121066
National Institutes of Health
Grant: 1R01DK115217
National Institutes of Health
Grant: NIAID-DAIT-NIHAI201700100
NIAID NIH HHS
Grant: AI201700100
Medical Research Council
Grant: MC_U117597139
Novo Nordisk Fonden
Grant: NNF19OC0058287
NIAID NIH HHS
Grant: R01 AI121066
The Francis Crick Institute
Grant: 10206
NIDDK NIH HHS
Grant: R01 DK115217
NIA NIH HHS
Grant: R21 AG064479
NIAID NIH HHS
Grant: R01 AI139512
Royal Society
Francis Crick Institute
Kent State University
King’s College London
Medical Research Council
National Cancer Institute
National Institutes of Health
FWCI
4.59
Citation Percentile
1.0%
Influential Citations
6
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals